On December 17, 2024, the House Task Force on Artificial Intelligence (Task Force) released a highly-anticipated report titled, “Bipartisan House Task Force Report on Artificial Intelligence,” (the Report) which establishes guiding principles and issues recommendations to guide U.S. innovation in artificial intelligence (AI), including in the healthcare sector. The Report is intended to serve as a blueprint for Members of Congress as they conduct oversight and introduce legislation to address advances in AI technologies, including the regulation of health-specific AI applications.
Latest Post
More Posts
FDA releases final guidance on 510(k) Third Party Review Program and Third Party Emergency Use Authorization (EUA) Review
FDA Clarifies Enforcement Policy Around Communications of Scientific Information on Unapproved Uses of Drugs and Medical Devices
FDA Proposes Framework to Assess AI Model Output Credibility to Support Regulatory Decision-Making
CMS Innovation Center Seeks Feedback on Medicare $2 Drug List Model
FDA Publishes FAQs Around Its Recent Laboratory Developed Tests Final Rule
FDA Issues Guidance on Using Electronic Health Records and Medical Claims Data in Clinical Studies
Subscribe: Subscribe via RSS
Firm/Org